Related Experiment Video
Updated: Aug 24, 2025
11:14
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
Published on: November 10, 2013
57.8K
Metal-Based Complexes in Cancer Treatment.
Tania Gamberi1, Muhammad Hanif2
1Department of Experimental and Clinical Biomedical Sciences, University of Florence, Viale Morgagni 50, 50134 Firenze, Italy.
Biomedicines
|October 27, 2022
Summary
Metal-based complexes are crucial cytotoxic agents. This research explores novel metal complexes for enhanced cancer treatment strategies.
Area of Science:
- Chemistry
- Pharmacology
Background:
- Metal-based complexes represent a significant class of chemotherapeutic agents.
- Their unique mechanisms of action offer alternatives to traditional organic drugs.
Discussion:
- This study investigates the synthesis and cytotoxic evaluation of novel metal complexes.
- The research focuses on structure-activity relationships to optimize anti-cancer properties.
Key Insights:
- Novel metal complexes demonstrate potent cytotoxic activity against various cancer cell lines.
- Specific structural modifications correlate with enhanced efficacy and reduced toxicity.
Outlook:
- Further preclinical and clinical studies are warranted to explore the therapeutic potential of these metal complexes.
- Development of targeted delivery systems could improve the clinical applicability of metal-based chemotherapeutics.
More Related Videos
Related Concept Videos
02:51Metal-Ligand Bonds
21.4K
The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
21.4K
01:09Complexation Equilibria: Factors Influencing Stability of Complexes
453
In complexation reactions, metal cations are the electron pair acceptors, and the ligands are the electron pair donors. The stability of the metal complexes depends primarily on the complexing ability of the central metal ion and the nature of the ligands. Generally, the complexing ability of the metal ion depends on the size and charge of the ion. As the metal ion size increases, the stability of the metal complexes decreases, provided that the valency of the metal ion and the ligands remain...
453
01:19Complexation Equilibria: The Chelate Effect
606
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
606
01:46Electron Transport Chain: Complex I and II
14.9K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K